Lambert, Bruce L <br/><br/>
Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia.  [electronic resource] 

 -  American journal of epidemiology  Oct 2006 
 - 672-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-9262 
<br/><br/><label>Standard No.: </label>10.1093/aje/kwj289  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antipsychotic Agents--adverse effects<br/>Benzodiazepines--adverse effects<br/>Case-Control Studies<br/>Cohort Studies<br/>Diabetes Mellitus, Type 2--epidemiology<br/>Dibenzothiazepines--adverse effects<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Olanzapine<br/>Proportional Hazards Models<br/>Quetiapine Fumarate<br/>Regression Analysis<br/>Risk Factors<br/>Risperidone--adverse effects<br/>Schizophrenia--drug therapy<br/>United States--epidemiology<br/>Veterans